Xiaoying Yu

Apr 10, 2023 | cell.com | Kathryn M. Hastie |Xiaoying Yu |Fernanda Ana-Sosa-Batiz |Dawid Zyla

Therapeutic antibodies are an important tool in the arsenal against coronavirus infection. However, most antibodies developed early in the pandemic have lost most or all efficacy against newly emergent strains of SARS-CoV2, particularly those of the Omicron lineage. Here, we report the identification of a panel of vaccinee-derived antibodies that have broad-spectrum neutralization activity.

Feb 14, 2023 | mdpi.com | Xiaoying Yu |Mengjie Song |Ze Wang

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticlebyXiaoying Yu *, Mengjie Song and Ze Wang School of Automation & Electrical Engineering, Lanzhou Jiaotong University, Lanzhou 730070, China*Author to whom correspondence should be addressed.